The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/appi.ps.201200590

Objective

This study examined disparity in bipolar disorder treatment for black and white Americans.

Methods

The sample included 167 respondents to the National Comorbidity Survey Replication who had lifetime type I or II bipolar disorder. Treatment adequacy and potential correlates were assessed.

Results

No black respondent received minimally adequate mood-stabilizing treatment, and blacks were less likely than whites to have taken a mood stabilizer in the prior year. Service use, sociodemographic characteristics, and symptom expression did not explain this disparity.

Conclusions

There was substantial racial inequality in bipolar disorder treatment. Issues guiding this disparity may be unique to this disorder, and clarification of the source of disparity is needed.